This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Sep. 12, 2013

R. Scott Shean

See more on R. Scott Shean

Latham & Watkins LLP | Costa Mesa | Practice type: Corporate

R. Scott Shean


Watson Pharmaceuticals Inc. - now a part of Actavis Group - has relied on Shean for its M&A work since the early 2000s. Titled Actavis Inc. since its purchase, the company is still a client bringing Shean exciting work.


Currently, Shean is representing Actavis in its proposed $8.5 billion purchase of rival drugmaker Warner Chilcott plc, based in Rockaway, N.J. Warner Chilcott has manufacturing plants across the world and would broaden Actavis' re...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up